Cases
Cases
Acorda’s liquidation trust is reconciling claims under a plan that became effective in August 2024. In its September 2026 post-confirmation report Dkt. 683, the trustee reported that final claim amounts and plan payments remained undetermined and anticipated applying for a final decree by June 30, 2027.
Analysis: Acorda Therapeutics Sells Assets to Merz for $185 Million, Liquidating Plan Confirmed
Updated Sep 8
| Month | Entries |
|---|---|
| April 2024 | 134 |
| May 2024 | 128 |
| June 2024 | 83 |
| July 2024 | 67 |
| August 2024 | 46 |
| September 2024 | 26 |
| October 2024 | 16 |
| November 2024 | 6 |
| December 2024 | 6 |
| January 2025 | 14 |
| February 2025 | 1 |
| March 2025 | 2 |
| April 2025 | 12 |
| May 2025 | 4 |
| June 2025 | 4 |
| July 2025 | 10 |
| August 2025 | 3 |
| September 2025 | 2 |
| October 2025 | 9 |
| November 2025 | 6 |
| December 2025 | 6 |
| January 2026 | 14 |
| February 2026 | 1 |
| March 2026 | 57 |
| April 2026 | 8 |
| May 2026 | 1 |
| June 2026 | 10 |
| July 2026 | 11 |
| August 2026 | 2 |
| September 2026 | 0 |
| October 2026 | 7 |
| November 2026 | 1 |
Case facts and filing dates come from court records.Case docket on PACER